Skip to main
University-wide Navigation

Consent Discussion Process

The consent process should allow for an exchange of information between the investigator and the subject. Even the best document is no substitute for two-way communication, interaction, and listening.

  • For complex or detailed studies, consider sending information and consent document in advance to allow potential participant time to review and think of questions.
  • Introduce yourself and take time to ask questions to assess prospective participant’s knowledge, experience, frame of mind, health literacy, motives, etc.
  • Actively listen!
  • Use plain language.  Be specific and concreate in communication.
  • Clarify what is and what is not part of the research (e.g., what will occur regardless of their participation such as standard of care procedures).
  • Describe foreign or technical concepts.
  • Use visual aids, glossary of terms, video or audio, illustrations, models or samples of interventional products.
  • Provide foundational education as needed (e.g., what is disease and standard treatment; what is a clinical trial, research purpose you are partnering with them to discover or solve)
  • If you are treatment provider, clarify that this is “research” to prevent therapeutic misconception.
  • If you are in a position of authority, reiterate that participation is totally voluntary and withdrawal is always an option (e.g., teachers, employers).
  • Use teach-back open-ended questions to assess understanding and clarify misperceptions.
  • After the study, evaluate your process by asking participant what they wish they would have known.

Posting Federally Funded Clinical Trial Consent Forms

View PDF

OHRP Frequently Asked Questions on Informed Consent

Visit Now